Ind-Swift

Chandigarh, India Founded: 1986 • Age: 40 yrs Listed
Pharmaceutical products, APIs, and herbal formulations are manufactured.

About Ind-Swift

Ind-Swift is a company based in Chandigarh (India) founded in 1986. The company has 1,124 employees. Ind-Swift offers products and services including Pharmaceutical Products and Ayurvedic Products.

  • Headquarter Chandigarh, India
  • Employees 1,124
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website indswiftltd.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Ind Swift Limited
  • Date of Incorporation 06 Jun, 1986
  • Jurisdiction Chandigarh, India
Key Metrics
  • Annual Revenue
    ₹560 Cr

    FY 2024 · +33% YoY

  • Net Profit
    ₹14.23 Cr

    FY 2024 · 3% margin

  • EBITDA
    ₹107 Cr

    FY 2024 · 19% margin

  • Employee Count
    1,124

Products & Services of Ind-Swift

Ind-Swift offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Ayurvedic Products.

Pharmaceutical Products
Healthcare

Manufacturing and marketing of ethical and generic drugs are conducted by Ind-Swift across various facilities.

Ayurvedic Products
Alternative Medicine

A variety of Ayurvedic products, such as juices, syrups, oils, and tablets, are provided by Ind-Swift for herbal health solutions.

Board of directors of Ind Swift Limited (Ind-Swift)

Ind Swift Limited is the primary company behind Ind-Swift. The board of Ind Swift Limited currently have 12 directors; the longest-serving is Gopal Munjal, appointed in 1986. 23 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gopal Munjal
DIN 00005196
Managing Director11 Dec 198639 yrs 9 moInd Swift Limited
Vikrant Rai Mehta
DIN 00010756
Whole-time director30 Sep 199333 yrsInd Swift Limited
Himanshu Jain
DIN 00014533
Director31 Jul 200323 yrs 2 moInd Swift Limited
Sanjeev Rai Mehta
DIN 00005668
Whole-time director30 Nov 200619 yrs 10 moInd Swift Limited
Navrattan Munjal
DIN 00015096
Director11 Dec 200619 yrs 9 moInd Swift Limited
Rishav Mehta
DIN 03028663
Additional Director23 Mar 201016 yrs 6 moInd Swift Limited
Subhash Chander Galhotra
DIN 07205416
Director31 Dec 20169 yrs 9 moInd Swift Limited
Anoop Michra
DIN 07813108
Director06 May 20179 yrs 5 moInd Swift Limited
Jagvir Singh Ahluwalia
DIN 06930649
Director29 Aug 20179 yrs 1 moInd Swift Limited
Bhupinder Singh
DIN 09649117
Director23 Jun 20224 yrs 3 moInd Swift Limited
Subodh Gupta
DIN 01393423
Director01 Apr 20242 yrs 6 moInd Swift Limited
Prabhat Khurana
DIN 03289193
Director01 Apr 20242 yrs 6 moInd Swift Limited

People of Ind-Swift

16 people are tracked at Ind-Swift (3 in leadership, 8 in board & advisors, 5 in team); the tracked headcount is 1,124.

NameRoleGroup
CEO & MDLeadership
Ravi Bhardwaj
Vice President Operations (plant Head)Leadership
Pratik Kumar
Vice-president ---r&dLeadership
S.C. Galhotra
Independent DirectorBoard & advisors
Independent Woman DirectorBoard & advisors
ChairmanBoard & advisors
Joint Managing DirectorBoard & advisors
DirectorBoard & advisors
J.S. Ahluwalia
Independent DirectorBoard & advisors
DirectorBoard & advisors
DirectorBoard & advisors
Richa Sharma
Senior ManagerTeam
Amit Sharma
GM - Operations - Indswift LTD Parwanoo.Team
Anirudh Sharma
Senior ExecutiveTeam
Monika Dua Rishi
Senior ManagerTeam
Avnish Kumar
Senior Research ScientistTeam
Premium access

Complete people profiles for Ind-Swift

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Ind-Swift

Figures of Ind Swift Limited, the primary company behind Ind-Swift, for FY 2024. Revenue was ₹560 Cr (+33% year on year). Net profit was ₹14.23 Cr (3% margin). EBITDA was ₹107 Cr (19% margin). Revenue has grown at a compounded annual rate of +15% over three years and +14% over five years.

  • ₹560 CrRevenue · FY 2024 · +33% YoY
  • ₹14.23 CrNet profit · 3% margin
  • ₹107 CrEBITDA · 19% margin
  • ₹25.03 CrPaid-up capital
  • 1,124Employees (provident fund records)
  • +15%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ind Swift Limited are on its company page.

Premium access

Detailed financial statements for Ind-Swift

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Ind-Swift

The website of Ind-Swift (indswiftltd.com) receives about 1.5K visits a month and ranks #8,422,180 among all websites worldwide, #7,365 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    1.5K

    ▼ 17.9% vs previous month

  • Global rank
    #8,422,180

    among all websites

  • Category rank
    #7,365

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Ind-Swift. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
indswiftlabs.com
100%
4.2K#3,680,932View details
unichemlabs.com
61%
4.6K#3,871,645View details
cooperpharma.com
61%
17.9K#1,398,892View details
fourrts.com
60%
13.9K#2,054,904View details
parpharm.com
60%
––View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for Ind-Swift

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Ind-Swift

Premium access

Complete news archive for Ind-Swift

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Ind-Swift

10 companies that operate in the same segment as Ind-Swift (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United States–USD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
1901Petah Tikva, Central District, IsraelUSD 500 MUSD 18.74 B51,792
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, India–USD 508.93 M5,180
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M––
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, India–USD 6.21 B25,870
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
1991Delhi, Delhi, IndiaUSD 367.2 MUSD 1.52 B21,320
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.
1967Mumbai, Maharashtra, India–USD 353.53 M3,410
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ind-Swift

Ind-Swift was founded in 1986.

Ind-Swift is headquartered in Chandigarh, India.

Gopal Munjal is the current CEO of Ind-Swift.

Ind-Swift has 1,124 employees.

The primary company behind Ind-Swift, Ind Swift Limited, reported revenue of β‚Ή560 Cr for FY 2024, up 33% year on year.

Ind-Swift was established in 1986 in Chandigarh, India, within the pharmaceuticals sector. Active pharmaceutical ingredients, finished dosage forms, and herbal products are produced. Operations include divisions for ethical, generic, and Ayurvedic medications. Research and development efforts are supported by a dedicated team focused on formulations and regulatory compliance. International exports are managed through a global business unit, with pharmaceutical franchise opportunities provided.

Ind-Swift offers Pharmaceutical Products and Ayurvedic Products.

Ind-Swift operates through Ind Swift Limited.

The legal entities of Ind-Swift currently have 13 directors, including Rishav Mehta, Himanshu Jain, Navrattan Munjal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available